These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12730108)

  • 1. The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutation.
    Koenen RR; Tans G; van Oerle R; Hamulyák K; Rosing J; Hackeng TM
    Blood; 2003 Sep; 102(5):1686-92. PubMed ID: 12730108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oral contraceptives on the anticoagulant activity of protein S in plasma.
    Koenen RR; Christella M; Thomassen LG; Tans G; Rosing J; Hackeng TM
    Thromb Haemost; 2005 May; 93(5):853-9. PubMed ID: 15886799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of the dysfunction of protein S(Tokushima) (Lys155-->Glu) for the regulation of the blood coagulation system.
    Hayashi T; Nishioka J; Suzuki K
    Biochim Biophys Acta; 1995 Dec; 1272(3):159-67. PubMed ID: 8541347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma.
    Alshaikh NA; Rosing J; Thomassen MCLGD; Castoldi E; Simioni P; Hackeng TM
    J Thromb Haemost; 2017 May; 15(5):950-960. PubMed ID: 28211163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of detergent sclerosants on antithrombotic mechanisms.
    Parsi K; Exner T; Low J; Ma DD; Joseph JE
    Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):220-8. PubMed ID: 19442540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprothrombinaemia-induced APC resistance: differential influence on fibrin formation and fibrinolysis.
    Binetti BM; Rotunno C; Tripodi A; Asti D; Semeraro F; Semeraro N; Colucci M
    Thromb Haemost; 2006 Apr; 95(4):606-11. PubMed ID: 16601829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?
    Oosting JD; Derksen RH; Bobbink IW; Hackeng TM; Bouma BN; de Groot PG
    Blood; 1993 May; 81(10):2618-25. PubMed ID: 8166780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin 20210G>A Carriers.
    Rühl H; Berens C; Winterhagen FI; Reda S; Müller J; Oldenburg J; Pötzsch B
    Circ Res; 2019 Aug; 125(5):523-534. PubMed ID: 31314700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation assay with improved specificity to factor V mutants insensitive to activated protein C.
    Kraus M; Zander N; Fickenscher K
    Thromb Res; 1995 Nov; 80(3):255-64. PubMed ID: 8578552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
    Wilmer M; Stocker C; Bühler B; Conell B; Calatzis A
    Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of activated protein C anticoagulant activity by prothrombin.
    Smirnov MD; Safa O; Esmon NL; Esmon CT
    Blood; 1999 Dec; 94(11):3839-46. PubMed ID: 10572099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities.
    Koenen RR; Gomes L; Tans G; Rosing J; Hackeng TM
    Thromb Haemost; 2004 Jun; 91(6):1105-14. PubMed ID: 15175796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity.
    Seré KM; Janssen MP; Willems GM; Tans G; Rosing J; Hackeng TM
    Biochemistry; 2001 Jul; 40(30):8852-60. PubMed ID: 11467946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a highly specific functional test for the detection of factor V Leiden.
    Quenhenberger P; Handler S; Mannhalter C; Pabinger-Fasching I; Speiser W
    Int J Clin Lab Res; 2000; 30(3):113-7. PubMed ID: 11196068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
    Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
    Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia.
    Castoldi E; Simioni P; Tormene D; Thomassen MC; Spiezia L; Gavasso S; Rosing J
    J Thromb Haemost; 2007 May; 5(5):971-9. PubMed ID: 17461930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.
    Santamaria S; Reglińska-Matveyev N; Gierula M; Camire RM; Crawley JTB; Lane DA; Ahnström J
    J Biol Chem; 2017 Jun; 292(22):9335-9344. PubMed ID: 28420729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine coagulation tests are not useful as a screening tool for the FII G20210A polymorphism.
    Rolla R; Pergolini P; Vidali M; Pollarolo P; Appiani A; Cerutti C; Manzini M; Crisci A; Bellomo G
    Clin Lab; 2014; 60(10):1725-33. PubMed ID: 25651720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C.
    Griffin JH; Kojima K; Banka CL; Curtiss LK; Fernández JA
    J Clin Invest; 1999 Jan; 103(2):219-27. PubMed ID: 9916134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.